-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Monday's Pre-Market Session
Share
Listen to the news

Gainers

  • Redhill Biopharma (NASDAQ:RDHL) shares increased by 96.7% to $1.3 during Monday's pre-market session. The market value of their outstanding shares is at $4.0 million.
  • Vivos Therapeutics (NASDAQ:VVOS) stock rose 50.15% to $0.34. The company's market cap stands at $4.5 million.
  • Beyond Air (NASDAQ:XAIR) shares rose 32.81% to $5.95. The market value of their outstanding shares is at $4.4 million.
  • Skye Bioscience (NASDAQ:SKYE) shares moved upwards by 11.54% to $1.98. The company's market cap stands at $7.8 million.
  • Cadrenal Therapeutics (NASDAQ:CVKD) stock increased by 11.03% to $1.71. The company's market cap stands at $5.4 million.
  • Conexeu Sciences (NASDAQ:CNXU) shares moved upwards by 9.01% to $7.71. The company's market cap stands at $189.1 million.

Losers

  • Zentek (NASDAQ:ZTEK) shares decreased by 29.6% to $0.38 during Monday's pre-market session. The company's market cap stands at $68.3 million.
  • Jupiter Neurosciences (NASDAQ:JUNS) stock fell 28.95% to $2.97. The market value of their outstanding shares is at $5.5 million.
  • NuCana (NASDAQ:NCNA) shares decreased by 14.78% to $1.5. The company's market cap stands at $7.3 million.
  • BioXcel Therapeutics (NASDAQ:BTAI) shares fell 13.51% to $0.16. The market value of their outstanding shares is at $5.6 million.
  • VolitionRX (AMEX:VNRX) shares fell 12.76% to $0.39. The market value of their outstanding shares is at $6.4 million.
  • Picard Medical (AMEX:PMI) shares fell 10.69% to $7.86. The market value of their outstanding shares is at $18.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending